v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows provided by operating activities:    
Net income $ 1,173,000 $ 1,464,000
Depreciation and amortization 127,000 85,000
Deferred income tax (benefit) expense (674,000) 255,000
Provision for credit losses 2,000
Impairment of inventory 12,000 15,000
Non-cash lease expense 173,000 99,000
Stock-based compensation 398,000 126,000
Accretion of discount on deferred purchase consideration 8,000
Change in operating assets and liabilities:    
(Increase) decrease in accounts receivable (50,000) 928,000
Decrease (increase) in inventory 75,000 (749,000)
Decrease in deferred COGS 70,000 341,000
(Increase) decrease in other current assets and other assets (22,000) 40,000
Decrease in state income tax receivable 21,000 10,000
Increase (decrease) in deferred revenue 55,000 (756,000)
Decrease in operating lease liability (159,000) (72,000)
(Decrease) increase in state income tax payable (14,000) 27,000
Increase (decrease) in accounts payable, accrued expenses, other current liabilities and non-current liabilities 81,000 (18,000)
Net cash provided by operating activities 1,276,000 1,795,000
Cash flows used in investing activities:    
Equipment, furniture and trade show booth purchases (9,000) (7,000)
Payment for exclusive distribution and commercialization rights (250,000)
Acquisition of Gen-Tracker business (1,000,000)
Patents (1,000)
Investments in technology (12,000) (13,000)
Leasehold improvements (11,000) (4,000)
Net cash used in investing activities (1,282,000) (25,000)
Cash flows provided by financing activities:    
Stock repurchases held in Treasury (16,000)
Stock option exercise proceeds 10,000 87,000
Net cash provided by financing activities 10,000 71,000
Net increase in cash 4,000 1,841,000
Cash at the beginning of the period 4,454,000 2,326,000
Cash at the end of the period 4,458,000 4,167,000
Cash paid during the year for:    
Interest
Income taxes 16,000 39,000
Non-cash investing and financing activities:    
Right-of-use assets 1,025,000
Operating lease liability 1,025,000
Deferred purchase consideration for Gen-Tracker Acquisition 2,059,000
Accrued preferred dividends to former CEO of OmniMetrix 3,000 3,000
Common stock issued in exchange for non-controlling interest and accrued preferred dividends in OmniMetrix $ 107,000